Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advisory bodies and committees (351)
- Scheduling (national classification system) (148)
- Prescription medicines (31)
- Advertising (24)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicines safety (19)
- Therapeutic goods regulation (18)
- Medical devices safety (12)
- Manufacturing (11)
- Complementary medicines (9)
- Safety (9)
- Non-prescription medicines (8)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Regulatory compliance (7)
- COVID-19 (6)
- Assessed listed medicines (5)
- Medicinal cannabis hub (5)
- Registered complementary medicines (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Alert/Advisory (2)
- Import and export (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Sunscreens (1)
Results for
"[search-keyword]"
Search
688 result(s) found, displaying 301 to 325
-
PublicationsProposal to prevent the uptake of nicotine containing e-cigarettes by ever users (adolescents and young adults), to support smoking cessation and to reduce nicotine poisonings of children
-
Scheduling decisions (final)Public notice of the delegate's final decision to amend the current Poisons Standard in relation to nicotine
-
Scheduling submissionsPublic submissions made in response to the interim decision on nicotine scheduling published on 23 September 2020
-
Scheduling decisions (final)Public notice of the delegate's final decision to amend the Poisons Standard in relation to cannabidiol (private application and delegate initiated) - Joint ACMS-ACCS #25 and #26 (June and November 2020).
-
Scheduling decisions (final)Decisions to be included in the February 2021 Poisons Standard
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
TGA laboratory testing reportsThe TGA has released a report summarising the recent laboratory testing of medicinal cannabis products
-
PublicationsInsights into manufacturing quality regulatory activity.
-
PublicationsThe TGA has published insights into recalls and GMP regulation for 2019-20.
-
PublicationsInsights into therapeutic goods safety regulatory activity for our recalls program.
-
Meeting statementsA meeting of the Therapeutic Goods Advertising Consultative Committee was held on 19 November 2020
-
Scheduling decisions (final)Final decisions on proposed amendments to the Poisons Standard - ACMS #31 (June 2020) and delegate only decisions relating to chemicals for agricultural and veterinary uses.
-
Scheduling decisions (final)Delegate only decisions to amend the Poisons Standard in relation to azo dyes (derivatives by diazotisation).
-
PublicationsResults of communication developmental research undertaken to inform consumer and health professional communication activities for the opioid regulatory reforms.
-
Scheduling decisions (interim)The closing date for public submissions on the delegate's interim decision on nicotine has been extended to Thursday 12 November 2020.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
PublicationsRead our clinician information sheet on opioid analgesic tapering: summary.
-
Scheduling decisions (final)Decisions to be included in the October 2020 Poisons Standard
-
Scheduling decisions (final)Public notice of the Delegates' final decisions to amend (or not amend) the current Poisons Standard in relation to melatonin.